Surgeons Discuss Treatment Recommendations for Thygeson Superficial Punctate Keratitis
A 20-year-old patient presents with a history of light sensitivity, decreased best-corrected visual acuity (BCVA), and challenges with night driving, attributed to Thygeson Superficial Punctate Keratitis (SPK). Despite a 5-year treatment regimen that included corticosteroids and various therapies like refractive lenses and cyclosporine, her symptoms remain unresolved.
In Cataract & Refractive Surgery Today, Dr. Stephen A. Wexler and colleagues review the case and offer insight into potential treatments, including PRK surgery. Dr. Wexler notes that while SPK often has little impact on visual acuity, this patient has experienced BCVA loss. He suggests PRK with MMC as a viable option to improve the patient’s vision, alongside oral tetracycline for rosacea treatment.
Learn more about this insightful case in Cataract & Refractive Surgery Today.